Exela Pharma Sciences LLC recalls 4.2% Sodium Bicarbonate Injection
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Impurities/Degradation Specifications: out of specification results for arsenic in the impurities tested.
- Products
-
- 4.2% Sodium Bicarbonate Injection
- Company
- Exela Pharma Sciences LLC
- Where it was sold
-
Nationwide in the USA
Nationwide
- Units affected
- N/A
- About this recall
- 4.2% Sodium Bicarbonate Injection, USP, 5 mEq/10 mL (0.5 mEq/mL), For Intravenous Use Only, 10 mL Single Dose Vial, Rx Only, Manufactured and Distributed by: Exela Pharma Sciences, LLC, Lenoir, NC 28645 USA, NDC 51754-5012-1 (vial); 51754-5012-4 (carton)